A24110He

N/A

Report date: 2024/11/08 10:47:56
NME

Base Information

Drug NameA24110He
Drug Alias NameA24110HeA-24110-He
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiopoietin-related protein 4 modulators
TargetsAngiopoietin-related protein 4
Therapy Area/IndicationsHypertriglyceridemiaHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLipigon Pharmaceuticals AB
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesApotek Produktion & Laboratorier AbLeaderna Therapeutics LtdChengdu Xianyan Derivatives Technology Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsHypertriglyceridemiaHyperlipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A